Navigation Links
BRIDION(R) (sugammadex) Injection - First and Only Selective Relaxant Binding Agent - Approved in European Union
Date:7/29/2008

BRIDION allows anesthesiologists to rapidly reverse both moderate and deep

levels of muscle relaxation First product approval from the Schering-Plough combination with Organon

BioSciences

KENILWORTH, N.J., July 29 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today announced that the European Commission (EC) has approved BRIDION(R) (sugammadex) injection, the first and only selective relaxant binding agent (SRBA) and the first major pharmaceutical advance in the field of anesthesia in two decades. BRIDION is indicated for routine reversal of the commonly used muscle relaxants rocuronium or vecuronium and for immediate reversal of rocuronium in adults, and for routine reversal following rocuronium in children and adolescents (2-17 years of age). Rocuronium and vecuronium are given as part of general anesthesia to relax a patient's muscles during surgery, and are marketed in Europe under the trade names ESMERON(R) and NORCURON(R), respectively.

BRIDION works in an entirely novel way by encapsulating the muscle relaxant molecule and rendering it inactive. It was specifically designed to reverse within minutes both moderate and deep muscle relaxation induced by rocuronium or vecuronium during general anesthesia. As a result, BRIDION can give anesthesiologists greater control in managing the depth of muscle relaxation through to the end of a surgical procedure. This may help improve surgical conditions in the millions of procedures where these agents are used.

"This approval of BRIDION represents the first advance in two decades for anesthesiologists and their patients, and has the potential to transform the practice of anesthesia," said Thomas P
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
2. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
3. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
4. Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
5. New Data to Support VELCADE(R) (Bortezomib) For Injection Based Therapies as Setting New Standards in The Care of Newly Diagnosed Patients With Multiple Myeloma
6. Isolagen Inc. Completes Injections of Isolagen Therapy(TM) in Phase III Wrinkle and Phase II Full Face Studies
7. FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
8. Millennium Expands VELCADE(R) (Bortezomib) For Injection Program In Non-Hodgkins Lymphoma
9. Inclusion of Six-Year Overall Survival Data in the Eloxatin(R) (oxaliplatin injection) Prescribing Information Granted FDA Priority Review
10. Circulation Publishes Data Showing KYNAPID(TM) (Vernakalant Hydrochloride) Injection Rapidly Converted Short-Duration Atrial Fibrillation to Sinus Rhythm
11. CorMatrix(R) Announces Intramyocardial Injection of Emulsified ECM Technology(TM) Demonstrates Enhanced Angiogenesis and Improved Cardiac Function in a Preclinical Model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... FRANCISCO , Oct. 22, 2014 Moms ... and health trackers for themselves and their kids, according ... 2014 Report: Health & Fitness Go Mobile for Moms, ... Insights Series. BabyCenter, the number 1 pregnancy and parenting ... found that 55 percent of moms surveyed say they ...
(Date:10/22/2014)... , Oct. 22, 2014 AVACEN Medical announced ... received 510 (k) OTC clearance by the U.S. Food ... to be marketed over the Internet for: the ... spasms; and minor strains and sprains . ... AVACEN 100 (MSRP $2495) is a sophisticated medical device ...
(Date:10/22/2014)... Oct. 22, 2014  CryoLife, Inc. (NYSE: ... company focused on cardiac and vascular surgery, announced today ... Chief Executive Officer, has been elected to the Company,s ... Steven G. Anderson , Executive Chairman of CryoLife, stated, ... to be an excellent leader who is well positioned ...
Breaking Medicine Technology:BabyCenter Finds Mom Ready to Live the "Measured Life" in its U.S. Mobile Mom 2014 Report: Health & Fitness Go Mobile for Moms 2BabyCenter Finds Mom Ready to Live the "Measured Life" in its U.S. Mobile Mom 2014 Report: Health & Fitness Go Mobile for Moms 3BabyCenter Finds Mom Ready to Live the "Measured Life" in its U.S. Mobile Mom 2014 Report: Health & Fitness Go Mobile for Moms 4AVACEN Medical Announces FDA Clearance of First Medical Device with Internal Game Mode 2Pat Mackin Joins CryoLife Board of Directors 2Pat Mackin Joins CryoLife Board of Directors 3
...  Global performance improvement solutions provider General Physics Corporation ... (NYSE: GPX ), today announced that its ... Award for Excellence in Marketing and Communications in the ... http://photos.prnewswire.com/prnh/20110404/MM77341LOGO-b ) The MarCom Awards is ...
... SAN FRANCISCO, Dec. 8, 2011 ClinStar, LLC , ... markets of Russia and Eastern Europe to the biopharmaceutical industry, ... Minutes series by Business Day TV hosted by Terry Bradshaw.  ... 10 to 15 years and over one billion dollars to launch ...
Cached Medicine Technology:GP's PerformTech Division Receives Prestigious MarCom Award 2GP's PerformTech Division Receives Prestigious MarCom Award 3ClinStar to Be Featured on Business Day TV With Terry Bradshaw 2
(Date:10/25/2014)... York (PRWEB) October 25, 2014 ... lawsuits ( http://www.vaginalmeshlawsuit2015.com/ ) filed against Boston ... in U.S. District Court, Southern District of West ... Judgment on Punitive Damages in a group of ... a ruling issued on October 21st, U.S. District ...
(Date:10/25/2014)... -- Interrupting blood supply to an arm or a leg ... the surgery, according to a new study. "During ... the heart to be able to operate on it. After ... ability to produce energy because it doesn,t get oxygen. When ... such as an arm or a leg, the body prepares ...
(Date:10/25/2014)... News) -- Researchers who discovered antibiotics in farmed ... for concern. The use of antibiotics in ... consumption contribute to the development of antibiotic-resistant bacteria ... from the study. Each year in the ... people and kill about 23,000, according to the ...
(Date:10/25/2014)... By Randy Dotinga ... -- As more genetic tests are developed that spot increased ... would be more proactive about getting screened. But a ... does not change behavior: People who found out their genes ... than people with average risk to get screened. "It ...
(Date:10/22/2014)... On Saturday, October 25, 2014, the Brownsville ... health and fitness fair ¡Vive tu vida! Get Up! Get ... nutrition for better health and wellness for people of all ... open to the public, will be held at Dean Porter ... to 1:00 pm. , “¡Vive tu Vida! Get Up! ...
Breaking Medicine News(10 mins):Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 4Health News:Brief Interruption of Blood Supply to Limb Might Aid Heart Surgery: Study 2Health News:Researchers Say Antibiotics in Fish a Health Concern 2Health News:Knowing Genetic Risk for Cancer May Not Change Behavior 2Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 2Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 3Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 4
... organise anniversary congress in Amsterdam (NL) , From May ... (ESPU) is organising its 20th annual congress. This anniversary ... things because of its high-quality scientific content. The congress ... Centre in the southern part of Amsterdam, The Netherlands. ...
... National Infertility Awareness Week(R), April 25 - May ... 27 Ferring Pharmaceuticals, which offers the broadest ... partnered with leading patient advocate organization, RESOLVE: The ... Nurse Liaison Program during National Infertility Awareness ...
... inspire people to mirror Mandela,s values NEW YORK, April 27 ... people around the world to support the creation of an ... July 18, Mr. Mandela,s birthday. This celebration of Nelson Mandela,s ... people to recognize their individual power to make an imprint ...
... the Assessment of the Urinary SystemCHICAGO, April 27 ... imaging systems to physician practices, announced today at the ... U.S. Food and Drug Administration (FDA) has granted 510(k) ... the assessment of urinary anatomy using multi-slice computed tomography ...
... Healthcare District Offers 23andMe Personal Genome Service™ at Health Centers to Encourage ... ... April 27, 2009 -- 23andMe , Inc., an industry leader in ... health district in California, today announced that PPH will be offering the ...
... Presented at American Society of Breast Surgeons Conference ... NEWS, Va., April 27 A study from ... that additional breast cancer was found in 9 ... was used to complement mammography, substantially impacting surgical ...
Cached Medicine News:Health News:Ferring Pharmaceuticals and RESOLVE: The National Infertility Association Join Together to Launch Nurse Liaison Program 2Health News:Ferring Pharmaceuticals and RESOLVE: The National Infertility Association Join Together to Launch Nurse Liaison Program 3Health News:46664 and the Nelson Mandela Foundation Call for Establishment of Global 'Mandela Day' 2Health News:46664 and the Nelson Mandela Foundation Call for Establishment of Global 'Mandela Day' 3Health News:46664 and the Nelson Mandela Foundation Call for Establishment of Global 'Mandela Day' 4Health News:46664 and the Nelson Mandela Foundation Call for Establishment of Global 'Mandela Day' 5Health News:Neuisys Announces FDA Clearance of UroCARE 2Health News:23andMe and Palomar Pomerado Health Partner to Give PPH Members Access to Their Genetic Information 2Health News:23andMe and Palomar Pomerado Health Partner to Give PPH Members Access to Their Genetic Information 3Health News:23andMe and Palomar Pomerado Health Partner to Give PPH Members Access to Their Genetic Information 4Health News:Further Testing With Breast-Specific Gamma Imaging (BSGI) Uncovers Additional Cancer in Breast Cancer Patients, Changes Surgical Management 2
The ultimate replacement device, the Contour MD ICD offers a maximum stored energy of 42 J. The device delivers high-energy defibrillation output and is ideal for patients with maximum energy defibri...
... a key participant in the area of ... decade. Previous Medtronic autotransfusion systems allowed clinicians ... well as to determine requirements for a ... (PRP) for a small amount of autologous ...
The RX HERCULINK® PLUS Biliary Stent System is Guidant's high performance .014" guide wire compatible system. It is available in stent diameters of 4.0-6.5mm for the 12mm stent length and 4.0-7.0...
... catheters comprise the world's broadest line ... procedures. Their advanced catheter design and ... response with a soft, atraumatic tip. ... sizes, Supreme and Response catheters provide ...
Medicine Products: